Dumont & Blake Investment Advisors LLC Has $2.52 Million Stock Holdings in MetLife, Inc. (NYSE:MET)

Dumont & Blake Investment Advisors LLC reduced its stake in MetLife, Inc. (NYSE:MET) by 50.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 30,522 shares of the financial services provider’s stock after selling 30,672 shares during the quarter. Dumont & Blake Investment Advisors LLC’s holdings in MetLife were worth $2,517,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its stake in MetLife by 3.4% during the first quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider’s stock worth $4,418,612,000 after purchasing an additional 1,974,268 shares during the period. Swedbank AB acquired a new stake in MetLife in the first quarter valued at approximately $131,456,000. Acadian Asset Management LLC increased its holdings in shares of MetLife by 7,837.0% during the second quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider’s stock valued at $79,250,000 after acquiring an additional 1,115,124 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of MetLife by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock worth $378,799,000 after purchasing an additional 988,666 shares during the period. Finally, Bessemer Group Inc. grew its position in MetLife by 29.7% in the 1st quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider’s stock valued at $157,133,000 after purchasing an additional 485,811 shares during the period. 89.81% of the stock is currently owned by institutional investors.

MetLife Trading Down 0.7 %

Shares of NYSE:MET traded down $0.58 on Friday, reaching $83.78. 306,300 shares of the company traded hands, compared to its average volume of 3,280,209. The business’s 50-day simple moving average is $79.37 and its 200 day simple moving average is $74.36. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.56. MetLife, Inc. has a 52 week low of $57.91 and a 52 week high of $86.94. The stock has a market capitalization of $58.67 billion, a P/E ratio of 22.58, a price-to-earnings-growth ratio of 0.70 and a beta of 1.04.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $2.28 EPS for the quarter, beating analysts’ consensus estimates of $2.13 by $0.15. The company had revenue of $17.82 billion during the quarter, compared to analyst estimates of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. The firm’s revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.94 EPS. As a group, equities analysts anticipate that MetLife, Inc. will post 8.58 EPS for the current fiscal year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be given a dividend of $0.545 per share. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 annualized dividend and a dividend yield of 2.60%. MetLife’s dividend payout ratio is presently 58.76%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on MET shares. Wells Fargo & Company raised their price objective on shares of MetLife from $86.00 to $92.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th. Jefferies Financial Group raised their price objective on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. TD Cowen began coverage on shares of MetLife in a research note on Wednesday, October 9th. They set a “buy” rating and a $97.00 price target for the company. Citigroup upped their price objective on MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a research note on Tuesday, July 23rd. Finally, Bank of America lowered their target price on MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, MetLife presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.46.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.